Abstract
HMGIC, a high-mobility-group protein gene encoding an architectural transcription factor, was recently identified as the target of gene fusion in a variety of human benign mesenchymal tumors; some of these events were chromosomal translocations involving 12q13–15. HMGIC consists of three DNA-binding domains (encoded by exons 1–3), a spacer, and an acidic carboxyl-terminal regulatory domain (exons 4–5). To determine the spectrum and nature of the aberrations in uterine myomas in Japanese patients, we systematically examined the tumors of 45 patients for all possible types of gene fusions involving HMGIC, by means of 3′-rapid amplification of cDNA ends (RACE) and reverse transcriptase-polymerase chain reaction (RT-PCR) experiments. HMGIC gene fusions were found in 16 (36%) of the tumors; aberrant splicings to five cryptic sequences located in introns of the HMGIC gene were found in 11 of these cases, and translocations causing juxtaposition to other genes, such as COX6C and RAD51B, were found in 5. In all fusion transcripts, the first two or three exons of HMGIC were fused to ectopic sequences. Our results suggest that a fusion event, resulting in the separation of the DNA-binding domains of HMGIC from the spacer and the acidic carboxyl-terminal regulatory domain, is a common tumorigenic mechanism in the development of uterine myomas.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: February 23, 2001 / Accepted: April 12, 2001
Rights and permissions
About this article
Cite this article
Mine, N., Kurose, K., Nagai, H. et al. Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas. J Hum Genet 46, 408–412 (2001). https://doi.org/10.1007/s100380170059
Issue Date:
DOI: https://doi.org/10.1007/s100380170059
This article is cited by
-
Novel role of COX6c in the regulation of oxidative phosphorylation and diseases
Cell Death Discovery (2022)
-
Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma
Pathology & Oncology Research (2012)
-
Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases
Modern Pathology (2010)
-
High-mobility group A (HMGA) genes: from solid to liquid tumours?
Leukemia (2005)
-
Clinicopathologic markers of uterine leiomyosarcoma originating from smooth muscle tumors of low malignancy
European Clinics in Obstetrics and Gynaecology (2005)